Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Ray Kim

Showing results (91-100 of 248) with videos related to

Pageof 25
Sort By:
Hepatology (Baltimore, Md.)|March 28, 2008
Serum activity of alanine aminotransferase (ALT) as an indicator of health and diseaseW Ray Kim, Steven L Flamm, Adrian M Di Bisceglie, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40W Ray Kim, Ajitha Mannalithara, Paul Y Kwo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 11, 2017
Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United StatesAllison Kwong, W Ray Kim, Ajitha Mannalithara, et al.
The Journal of Family Practice|April 20, 2010
Overview of the viral hepatitis problemAnna S F Lok, W Ray Kim, Hashem B El-Serag, et al.
Gastroenterology|April 16, 2013
Underestimation of liver-related mortality in the United StatesSumeet K Asrani, Joseph J Larson, Barbara Yawn, et al.
Archives of Internal Medicine|September 12, 2012
Hepatitis B screening in a US academic primary care practiceNicole M Loo, W Ray Kim, Joseph J Larson, et al.
Radiology|April 9, 2013
Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastographyDonghee Kim, W Ray Kim, Jayant A Talwalkar, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Benchmarking clinical risk prediction algorithms with ensemble machine learning: An illustration of the superlearner algorithm for the non-invasive diagnosis of liver fibrosis in non-alcoholic fatty liver diseaseVivek Charu, Jane W Liang, Ajitha Mannalithara, et al.
Hepatology (Baltimore, Md.)|April 30, 2024
Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLDVivek Charu, Jane W Liang, Ajitha Mannalithara, et al.
Cancer|July 22, 2014
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk modelJennifer A Flemming, Ju Dong Yang, Eric Vittinghoff, et al.
Pageof 25

Showing results (91-100 of 248) with videos related to

Sort By:
Pageof 25
Hepatology (Baltimore, Md.)|March 28, 2008
Serum activity of alanine aminotransferase (ALT) as an indicator of health and diseaseW Ray Kim, Steven L Flamm, Adrian M Di Bisceglie, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40W Ray Kim, Ajitha Mannalithara, Paul Y Kwo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 11, 2017
Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United StatesAllison Kwong, W Ray Kim, Ajitha Mannalithara, et al.
The Journal of Family Practice|April 20, 2010
Overview of the viral hepatitis problemAnna S F Lok, W Ray Kim, Hashem B El-Serag, et al.
Gastroenterology|April 16, 2013
Underestimation of liver-related mortality in the United StatesSumeet K Asrani, Joseph J Larson, Barbara Yawn, et al.
Archives of Internal Medicine|September 12, 2012
Hepatitis B screening in a US academic primary care practiceNicole M Loo, W Ray Kim, Joseph J Larson, et al.
Radiology|April 9, 2013
Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastographyDonghee Kim, W Ray Kim, Jayant A Talwalkar, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Benchmarking clinical risk prediction algorithms with ensemble machine learning: An illustration of the superlearner algorithm for the non-invasive diagnosis of liver fibrosis in non-alcoholic fatty liver diseaseVivek Charu, Jane W Liang, Ajitha Mannalithara, et al.
Hepatology (Baltimore, Md.)|April 30, 2024
Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLDVivek Charu, Jane W Liang, Ajitha Mannalithara, et al.
Cancer|July 22, 2014
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk modelJennifer A Flemming, Ju Dong Yang, Eric Vittinghoff, et al.
Pageof 25